StockNews.AI
ARDX
StockNews.AI
98 days

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDX

1. Pomerantz LLP is investigating claims against Ardelyx for potential securities fraud. 2. Ardelyx's Q1 2025 results missed expectations, leading to a stock price drop. 3. GAAP EPS was $0.17, missing consensus by $0.07. 4. Total operating expenses increased by 54% year-over-year. 5. Stock price fell 24.5% to $4.13 following the earnings report.

3m saved
Insight
Article

FAQ

Why Very Bearish?

The investigation into fraud and poor financial results will severely damage investor confidence. Historical examples, such as Valeant Pharmaceuticals, show similar crises leading to significant drops in stock prices.

How important is it?

The investigation and recent financial performance directly impact Ardelyx's market perception and valuation significantly.

Why Short Term?

The next few quarters will likely reflect ongoing investor concern and possible legal ramifications. Immediate fear of a class-action lawsuit could lead to further volatility.

Related Companies

VRXCELGNVS
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Ardelyx, Inc. (“Ardelyx” or the “Company”) (NASDAQ: ARDX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ardelyx and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On May 1, 2025, Ardelyx issued a press release reporting its financial results for the first quarter of 2025.  Among other items, Ardelyx reported GAAP earnings per share of $0.17 on revenue of $74.1 million, missing consensus estimates by $0.07 and $5.34 million, respectively.  Ardelyx also reported a 54% year-over-year increase in its total operating expenses.  On this news, Ardelyx’s stock price fell $1.34 per share, or 24.5%, to close at $4.13 per share on May 2, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes.    CONTACT:Danielle PeytonPomerantz LLPdpeyton@pomlaw.com646-581-9980 ext. 7980

Related News